Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Huntington Disease l: Introduction
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Acute Coronary Syndrome III: Diagnostic Studies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 19, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
1intensive care unit at Virtua Health in Voorhees, NJ, USA.
No abstract available in PubMed .